Bhuvaneswari, Ramaswamy <br/><br/>
Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.  [electronic resource] 

 -  Molecular cancer  Nov 2009 
 - 94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-4598 
<br/><br/><label>Standard No.: </label>10.1186/1476-4598-8-94  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Apoptosis--drug effects<br/>Cetuximab<br/>Combined Modality Therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Mice<br/>Phosphorylation--drug effects<br/>Photochemotherapy<br/>Remission Induction<br/>Urinary Bladder Neoplasms--drug therapy<br/>Xenograft Model Antitumor Assays